These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6426309)

  • 21. Limited capacity for renal vasodilatation in anesthetized diabetic rats.
    Ha H; Dunham EW
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H845-55. PubMed ID: 3661732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
    Susić H; Malik KU
    J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat.
    Messina EJ; Weiner R; Kaley G
    Circ Res; 1975 Oct; 37(4):430-7. PubMed ID: 1182934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandins and renal blood flow: in vivo studies.
    Lifschitz MD
    Kidney Int; 1981 Jun; 19(6):781-5. PubMed ID: 6790809
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostaglandins: renal vascular responses to bradykinin, histamine, and nitroglycerine.
    Feigen LP; Chapnick BM; Flemming JE; Kadowitz PJ
    Am J Physiol; 1978 Apr; 234(4):H496-502. PubMed ID: 417634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked to activation of alpha-1 adrenergic receptors in the isolated rat kidney.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1985 Apr; 233(1):24-31. PubMed ID: 2858580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No role for prostaglandins and bradykinin in the autoregulation of renal blood flow.
    Ogawa N; Ono H
    Jpn J Pharmacol; 1985 Nov; 39(3):349-55. PubMed ID: 3937925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog.
    Oliver JA; Sciacca RR; Pinto J; Cannon PJ
    J Clin Invest; 1981 Jan; 67(1):229-37. PubMed ID: 7005264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of bradykinin-induced renin release by indomethacin in anesthetized rats.
    Suzuki M; Satoh S
    Clin Exp Hypertens A; 1984; 6(6):1227-35. PubMed ID: 6430607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists.
    Banks RO; Jacobson ED
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F851-7. PubMed ID: 2866716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin control of renal circulation in the unanesthetized dog and baboon.
    Swain JA; Heyndrickx GR; Boettcher DH; Vatner SF
    Am J Physiol; 1975 Sep; 229(3):826-30. PubMed ID: 1211476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
    Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of Ca++ and calmodulin to the action of norepinephrine on renal prostaglandin synthesis and vascular tone.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1986 Feb; 236(2):424-31. PubMed ID: 3080585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of eicosanoid synthesis inhibitors on normoxic and hypoxic pulmonary vascular tone in dogs.
    Rubin LJ; Hughes JD; Lazar JD
    Am Rev Respir Dis; 1985 Jul; 132(1):93-8. PubMed ID: 3925829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of angiotensins (I, II, & III), bradykinin and arachidonic acid on renomedullary PGE production in vitro.
    Anees M; Sweet P; Tan SY; Mulrow PJ
    Prostaglandins; 1979 Apr; 17(4):515-23. PubMed ID: 111307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid.
    Feigen LP; Chapnick BM; Flemming JE; Flemming JM; Kadowitz PJ
    Am J Physiol; 1977 Nov; 233(5):H573-9. PubMed ID: 920820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam.
    Baer PG; Cagen LM
    Hypertension; 1987 Mar; 9(3):253-60. PubMed ID: 3818022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial impairment inhibits prostaglandin and EDRF-mediated arteriolar dilation in vivo.
    Koller A; Messina EJ; Wolin MS; Kaley G
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1966-70. PubMed ID: 2513732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indomethacin and meclofenamate potentiation of skeletal muscle active hyperemia.
    Rankin RS; Klabunde RE
    Life Sci; 1985 Jan; 36(2):161-8. PubMed ID: 3917524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins.
    Hofbauer KG; Dienemann H; Forgiarini P; Stalder R; Wood JM
    Gen Pharmacol; 1983; 14(1):145-7. PubMed ID: 6826026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.